The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK BROKER RATINGS: Goldman Cuts Antofagasta, Raises Anglo American

Fri, 23rd Jan 2015 09:52

LONDON (Alliance News) - The following UK shares received analyst recommendations Friday morning and Thursday afternoon:
----------
FTSE 100
----------
SOCGEN RAISES REED ELSEVIER PRICE TARGET TO 1275 (1105) PENCE - 'BUY'
----------
SOCGEN RAISES WPP PRICE TARGET TO 1685 (1530) PENCE - 'BUY'
----------
SOCGEN RAISES PEARSON PRICE TARGET TO 1220 (1105) PENCE - 'HOLD'
----------
SOCGEN RAISES ITV PRICE TARGET TO 240 (220) PENCE - 'HOLD'
----------
SOCGEN RAISES SKY PLC PRICE TARGET TO 1110 (1045) PENCE - 'BUY'
----------
BERENBERG CUTS CENTRICA PRICE TARGET TO 300 (370) PENCE - 'BUY'
----------
BERNSTEIN CUTS HSBC PRICE TARGET TO 660 (800) PENCE - 'OUTPERFORM'
----------
BERENBERG RAISES ASTRAZENECA PRICE TARGET TO 4800 (4240) PENCE - 'HOLD'
----------
BERENBERG RAISES GLAXOSMITHKLINE PRICE TARGET TO 1620 (1540) PENCE - 'HOLD'
----------
BERENBERG CUTS INTERTEK PRICE TARGET TO 2375 (2800) PENCE - 'HOLD'
----------
BARCLAYS RAISES ST JAMES'S PLACE PRICE TARGET TO 939 (916) PENCE - 'OVERWEIGHT'
----------
TRADERS: GOLDMAN CUTS ANTOFAGASTA TO 'NEUTRAL' ('BUY')
----------
JPMORGAN CUTS ANTOFAGASTA PRICE TARGET TO 710 (755) PENCE - 'NEUTRAL'
----------
TRADERS: GOLDMAN RAISES ANGLO AMERICAN TO 'NEUTRAL' ('SELL')
----------
JPMORGAN CUTS ANGLO AMERICAN PRICE TARGET TO 1120 (1340) PENCE - 'UNDERWEIGHT'
----------
UBS CUTS EXPERIAN TO 'NEUTRAL' ('BUY')
----------
CITIGROUP RAISES ST JAMES'S PLACE PRICE TARGET TO 1000 (870) PENCE - 'BUY'
----------
NUMIS RAISES ST JAMES'S PLACE PRICE TARGET TO 980 (850) PENCE - 'ADD'
----------
CITIGROUP CUTS WEIR GROUP PRICE TARGET TO 1750 (1900) PENCE - 'NEUTRAL'
----------
MORGAN STANLEY RAISES IAG PRICE TARGET TO 7.50 (6.60) EUR - 'OVERWEIGHT'
----------
NUMIS RAISES WHITBREAD PRICE TARGET TO 5600 (5150) PENCE - 'ADD'
----------
JPMORGAN RAISES WHITBREAD PRICE TARGET TO 5250 (5000) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES COMPASS GROUP PRICE TARGET TO 1150 (1050) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES FRESNILLO PRICE TARGET TO 1190 (1110) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES INTERCONTINENTAL HOTELS TARGET TO 2600 (2200) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES WHITBREAD PRICE TARGET TO 5250 (5000) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS BHP BILLITON PRICE TARGET TO 1550 (1870) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS RIO TINTO PRICE TARGET TO 3400 (3500) PENCE - 'OVERWEIGHT'
----------
FTSE 250
----------
JPMORGAN RAISES BETFAIR PRICE TARGET TO 1600 (1510) PENCE - 'OVERWEIGHT'
----------
NUMIS RAISES BALFOUR BEATTY TO 'ADD' ('HOLD') - TARGET 230 PENCE
----------
SOCGEN RAISES INFORMA TO 'BUY' ('HOLD') - TARGET 585 (500) PENCE
----------
UBS CUTS OXFORD INSTRUMENTS PRICE TARGET TO 950 (1300) PENCE - 'BUY'
----------
BERENBERG CUTS OXFORD INSTRUMENTS TO 'HOLD' ('BUY') - TARGET 950 (1360) PENCE

BARCLAYS CUTS OXFORD INSTRUMENTS PRICE TARGET TO 860 (1140) PENCE - 'EQUALWEIGHT'

JPMORGAN CUTS OXFORD INSTRUMENTS TARGET TO 1200 (1350) PENCE - 'OVERWEIGHT'

UBS CUTS RENTOKIL INITIAL TO 'SELL' ('NEUTRAL') - TARGET 112 PENCE
----------
UBS CUTS OPHIR ENERGY PRICE TARGET TO 150 (230) PENCE - 'NEUTRAL'
----------
BARCLAYS CUTS ELECTROCOMPONENTS PRICE TARGET TO 210 (229) PENCE - 'EQUALWEIGHT'
----------
BARCLAYS CUTS PREMIER FARNELL PRICE TARGET TO 188 (205) PENCE - 'EQUAL WEIGHT'
----------
TRADERS: JPMORGAN CUTS TELECITY GROUP TO 'NEUTRAL' ('OVERWEIGHT')
----------
TRADERS: MORGAN STANLEY CUTS MICHAEL PAGE TO 'EQUAL-WEIGHT' ('OVERWEIGHT')
----------
UBS CUTS MICHAEL PAGE TO 'NEUTRAL' ('BUY')
----------
EXANE BNP CUTS CRODA TO 'NEUTRAL' ('OUTPERFORM') - TARGET 2770 (2820) PENCE
----------
EXANE BNP CUTS ELEMENTIS TO 'NEUTRAL' ('OUTPERFORM') - TARGET 300 PENCE
----------
CITIGROUP RAISES HENDERSON GROUP PLC PRICE TARGET TO 246 (218) PENCE - 'BUY'
----------
MORGAN STANLEY RAISES HAYS PRICE TARGET TO 165 (160) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS TELECITY TO 'NEUTRAL' ('OVERWEIGHT') - TARGET 900 (925) PENCE
----------
JPMORGAN RAISES LADBROKES PRICE TARGET TO 110 (95) PENCE - 'UNDERWEIGHT'
----------
JPMORGAN RAISES PLAYTECH PRICE TARGET TO 635 (615) PENCE - 'NEUTRAL'
----------
JPMORGAN RAISES SSP GROUP PRICE TARGET TO 320 (310) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS KAZ MINERALS PRICE TARGET TO 335 (365) PENCE - 'OVERWEIGHT'
----------
JPMORGAN CUTS VEDANTA PRICE TARGET TO 530 (960) PENCE - 'NEUTRAL'
----------
MAIN MARKET AND AIM
----------
SOCGEN CUTS DAILY MAIL PRICE TARGET TO 720 (740) PENCE - 'SELL'
----------
JPMORGAN RAISES GEM DIAMONDS PRICE TARGET TO 290 (280) PENCE - 'OVERWEIGHT'
----------
JPMORGAN RAISES HOCHSCHILD MINING PRICE TARGET TO 130 (125) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS FERREXPO PRICE TARGET TO 80 (110) PENCE - 'NEUTRAL'
----------
JPMORGAN CUTS PETROPAVLOVSK PRICE TARGET TO 9 (10) PENCE - 'UNDERWEIGHT'
----------
By Arvind Bhunjun; arvindbhunjun@alliancenews.com; @ArvindBhunjun

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
9 Jan 2024 10:50

Novartis in advanced talks to buy Cytokinetics- source

Jan 9 (Reuters) - Swiss drugmaker Novartis is in the lead to acquire Cytokinetics in a deal that could value the drug developer at well over $10 billion, a source familiar with the matter said on Monday.

Read more
8 Jan 2024 14:08

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
6 Jan 2024 17:44

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
5 Jan 2024 12:00

Late M&A bonanza stokes healthcare dealmakers ahead of JPMorgan conference

NEW YORK, Jan 5 (Reuters) - Healthcare dealmakers are making their way to San Francisco for a major industry conference, optimistic that more deals are in the offing after a wave of biotech company takeovers at the end of last year.

Read more
3 Jan 2024 17:48

London close: Stocks fall amid rising geopolitical concerns

(Sharecast News) - London stocks closed lower on Wednesday - the 40th anniversary of the FTSE 100's launch - as sentiment remained cautious due to increasing tensions in the Middle East.

Read more
3 Jan 2024 16:52

LONDON MARKET CLOSE: Stocks down ahead of US Fed minutes

(Alliance News) - Stock prices in London closed lower on Wednesday, as investors nervously look ahead to the latest US Federal Reserve meeting minutes.

Read more
3 Jan 2024 11:07

Jefferies upgrades GSK to 'buy', cuts AstraZeneca to 'hold'

(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector.

Read more
3 Jan 2024 10:16

IN BRIEF: Nuformix narrows annual loss as develops drug assets

Nuformix PLC - London-based developer of treatments for fibrosis and oncology via drug repurposing - Pretax loss narrows to GBP927,972 in 18 months that ended September 30 from GBP1.3 million in the 12 months that ended March 31, 2022, following its change of financial year-end. Has no meaningful revenue in either period, so reduced loss is due to lower administrative expenses.

Read more
3 Jan 2024 10:12

AIM WINNERS & LOSERS: C4X gets Astra payment; Getech wins eight deals

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

Read more
3 Jan 2024 09:23

LONDON BROKER RATINGS: GSK raised to 'buy'; AstraZeneca cut to 'hold'

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
3 Jan 2024 08:58

LONDON MARKET OPEN: Stocks mixed pre-Fed minutes, amid Asia losses

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of US Federal Reserve meeting minutes and manufacturing PMI data for the US in the evening and afternoon respectively.

Read more
3 Jan 2024 08:04

C4X receives USD11 million from AstraZeneca following NRF2 trials

(Alliance News) - C4X Discovery Holdings PLC on Wednesday said it has received payment from AstraZeneca PLC following trials of the C4X respiratory disease therapy treatment.

Read more
3 Jan 2024 07:54

LONDON BRIEFING: Stocks to open flat pre-Fed minutes, jobs data

(Alliance News) - The FTSE 100 is expected to open flat on Wednesday, as London's flagship index celebrates its 40th anniversary, after mostly downbeat trading in Asia and a tech sell-off in New York.

Read more
2 Jan 2024 17:05

British equities slip on higher yields, financials drag

FTSE 100 down 0.2%, FTSE 250 off 0.9%

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.